Tweet by Carlat Psychiatry on Twitter

7V2KCmUv_normal.jpg spacer.png
Carlat Psychiatry
⁦‪@CarlatPsych‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Read the inaugural issue of The Carlat Geriatric Psychiatry Report! Subscribe for CME, read the first issue free! Editor in Chief, Stephanie Collier, MD, Division of Geriatric Psychiatry at ⁦‪@McLeanHospital‬⁩ and instructor in psychiatry at ⁦‪@harvardmed‬⁩ thecarlatreport.com/product/the-ca… pic.twitter.com/JcsULHqUU6
5/3/22, 8:16 AM

NYTimes.com: Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims

From The New York Times:

Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims

The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.

https://www.nytimes.com/2022/04/28/health/obesity-drug-eli-lilly-tirzepatide-wegovy.html?smid=em-share

Telepsychiatry Initiatives at an Academic Medical Center Department of Psychiatry: Enabling Sustainable Growth

This model may be useful in addressing the challenges for UF Psychiatry and Behavioral Health as it expands its footprint to Central Florida and elsewhere Joe

https://www.psychiatrictimes.com/view/telepsychiatry-initiatives-at-an-academic-medical-center-department-of-psychiatry-enabling-sustainable-growth

Tweet by Carla Cobb, PharmD, BCPP 🏥👩‍⚕️😷 🇺🇸🇨🇦 on Twitter

nRcJ1HCj_normal.jpg spacer.png
Carla Cobb, PharmD, BCPP 🏥👩‍⚕️😷🇺🇸🇨🇦
⁦‪@PtCarePharm‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Excellent presentation by Dr. ⁦‪@thomasinselmd‬⁩ today at #CPNP2022 . We can improve outcomes for people with psychiatric disorders but it will take some uncomfortable changes. We need to hold providers accountable for evidence-based, high quality care. pic.twitter.com/uhGF21YGNh
4/25/22, 7:56 AM